Skip to content

Cerus CERS Interest coverage

Interest coverage at other companies

CorMedix logo
CorMedixCRMD
54×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
22.7×+17.6×
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
-5.2×-6.9×
ADMA Biologics logo
ADMA BiologicsADMA
29.7×+17.2×

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Calculated from Cerus’s reported figures.

Based on trailing twelve months.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's interest coverage?
Cerus (CERS) reported interest coverage of -0.4× in Q1 2026.
How has Cerus's interest coverage changed year-over-year?
Cerus's interest coverage increased by 71.6% year-over-year, from -1.4× to -0.4×.
What is the long-term trend for Cerus's interest coverage?
Over 5 years (2020 to 2025), Cerus's interest coverage has grown at a -41.8% compound annual growth rate (CAGR), from -15.6× to -1×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.